Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A brings in $3.2mm so far for Harpoon Medical; Univ. of MD, Baltimore adds $100k

Executive Summary

Cardiology device developer Harpoon Medical Inc. raised $3.2mm so far in its Series A financing led by Epidarex Capital, which was joined by the Maryland Venture Fund, Abell Foundation, and MD angel investors. Earlier this year the start-up licensed cardiac valve repair IP from the University of Maryland, Baltimore. Harpoon Medical is incorporating the technology into a minimally invasive image-guided device designed to surgically repair mitral valve function and eliminate regurgitation via a one-hour procedure.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies